Mechanical circulatory support-Challenges, strategies, and preparations.

Published in: Journal of cardiac surgery (2021)

HF incidence, prevalence, and undertreatment will grow as a result of new COVID-19-related heart disease. ECMO should be reserved for highly selected cases of COVID-19 with a reasonable probability of recovery. Special considerations are needed for patients with advanced HF, including those supported by durable LVADs.

Keyphrases

coronavirus disease
sars cov
extracorporeal membrane oxygenation
risk factors
acute respiratory distress syndrome
acute heart failure
pulmonary hypertension
respiratory syndrome coronavirus
intensive care unit
respiratory failure
atrial fibrillation